These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 26998693)
1. Epidemiology and radiological geometric assessment of pituitary macroadenomas: population-based study. Gruppetta M; Vassallo J Clin Endocrinol (Oxf); 2016 Aug; 85(2):223-31. PubMed ID: 26998693 [TBL] [Abstract][Full Text] [Related]
2. Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas. Zada G; Lin N; Laws ER Neurosurg Focus; 2010 Oct; 29(4):E4. PubMed ID: 20887129 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and incidence of pituitary adenomas: a population based study in Malta. Gruppetta M; Mercieca C; Vassallo J Pituitary; 2013 Dec; 16(4):545-53. PubMed ID: 23239049 [TBL] [Abstract][Full Text] [Related]
4. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775 [TBL] [Abstract][Full Text] [Related]
5. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. Micko AS; Wöhrer A; Wolfsberger S; Knosp E J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782 [TBL] [Abstract][Full Text] [Related]
6. Incidence of pituitary adenomas in Northern Finland in 1992-2007. Raappana A; Koivukangas J; Ebeling T; Pirilä T J Clin Endocrinol Metab; 2010 Sep; 95(9):4268-75. PubMed ID: 20534753 [TBL] [Abstract][Full Text] [Related]
13. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina. Day PF; Loto MG; Glerean M; Picasso MF; Lovazzano S; Giunta DH Arch Endocrinol Metab; 2016; 60(6):554-561. PubMed ID: 27982201 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Daly AF; Rixhon M; Adam C; Dempegioti A; Tichomirowa MA; Beckers A J Clin Endocrinol Metab; 2006 Dec; 91(12):4769-75. PubMed ID: 16968795 [TBL] [Abstract][Full Text] [Related]
15. The epidemiology of pituitary adenomas in a community-based hospital: a retrospective single center study in Saudi Arabia. Aljabri KS; Bokhari SA; Assiri FY; Alshareef MA; Khan PM Ann Saudi Med; 2016; 36(5):341-345. PubMed ID: 27710986 [TBL] [Abstract][Full Text] [Related]
16. Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation. Levine SN; Ishaq S; Nanda A; Wilson JD; Gonzalez-Toledo E Ann Diagn Pathol; 2013 Aug; 17(4):361-6. PubMed ID: 23602507 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome. Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas. Larouche V; Correa JA; Cassidy P; Beauregard C; Garfield N; Rivera J Pituitary; 2016 Apr; 19(2):202-9. PubMed ID: 26700946 [TBL] [Abstract][Full Text] [Related]